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ABSTRACT 
 
Introduction: Post operative nausea and vomiting is one of the most common and annoying problem after general 
anesthesia resulting in patient discomfort, delaying discharge from recovery unit and may be at time dangerous 
resulting in pulmonary aspiration syndrome. Patients undergoing thyroid surgeries are at high risk for development 
of PONV with reporting incidence of 63% to 84%. We compare the efficacy of propofol, Ondansetron and 
dexamethasone to prevent PONV. Material and Methods: 60 adult patients undergoing elective partial or total 
thyroidectomy were placed in 3 groups (20 patients in each group) 
 Group 1 : Propofol 0.5 mg/kg (15 minutes before reversal) 
 Group 2 : Ondansetron 8 mg (15 minutes before induction) 
 Group 3 : Dexamethasone 10 mg (15 minutes after induction) 
Postoperatively all patients were assessed for the incidence of nausea, vomiting, vital parameters, pain and sedation 
score, occurrence of sore throat, requirement of rescue antiemetic and other complications for every 4 hours for 24 
hours except during sleep. Results: Occurrence of PONV was high in group 3 (10%) during first 4 hours 
postoperatively as compared to other two groups. The entire three groups had similar efficacy in preventing PONV 
during 4-8 hours postoperatively.  Between 8 to 20 hours the incidence is high in group 1 and 2 as compared to 
group 3.Complete response to PONV in group 3 was found during 12-24 hours while in group 1 and 2 in 20-24 
hours postoperatively. Group 3 found to be the most effective in our study. Conclusion: Overall incidence of PONV 
in the first 24 hour period was 35% in group 1, 25% in group 2 and 20% in group 3. Stastically significant difference 
in the incidence of PONV was noted between group 3 and group 1 & 2. Group 3 found to be the most effective in 
our study. Delayed emesis is better controlled with Dexamethasone compared with other groups. All three groups 
found to be effective in preventing PONV as a complete response in later part of post operative period. 
 
Keywords: Post operative nausea and vomiting, General Anesthesia, Dexamethasone, Propofol, Ondansetron, 
Thyroidectomy 
Introduction 
 
 
PONV is one of the most common and annoying 
problem after general anesthesia and occurs in about 
20-30% of patient’s inspite of the newer antiemetic 
being used. PONV after thyroidectomy is especially 
frequent with reported rate of 63-84%. PONV results in 
patient discomfort, delays discharge from recovery unit 
and may be dangerous and lead to one of the 
pulmonary aspiration syndrome. PONV is 
multifactorial in nature and depends on the patient 
factors, anesthesia techniques used, surgical procedure 
and certain post operative events. A large number of 
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drugs in the form of antihistaminics, 5HT3 receptor 
antagonists, dexamethasone & propofol are being used 
currently as an antiemetic to prevent PONV.  
Aim: The study was designed to compare the effect of 
propofol, Ondansetron & Dexamethasone to prevent 
PONV particularly in thyroid surgery. 
 To find out the efficacy of the three groups in 
preventing PONV and requirement of rescue 
antiemetics 
 To study the effect of antiemetics used on 
vital parameters, pain & sedation score and 
analgesic consumption in post-operative 
period. 
Material & Methods  
 
60 adult patients ranging from 20 to 65 years of both 
sexes undergoing total/subtotal thyroidectomy were 
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selected for the study. Patients were assessed adequately 
in the pre-operative period. Through history and clinical 
examination, investigations were conducted and analyzed. 
Only patients belonging to ASA Ι & ΙΙ were selected for 
the study. 
Exclusion Criteria 
 
 Intra thoracic goiter 
 Gastrointestinal disorder 
 H/O motion sickness 
 Patients who had received an antiemetic within 48 
hours before surgery 
 Patients who have suffered difficult endotracheal 
intubation at the time of induction 
After obtaining institutional review board approval, 
written informed consent was obtained from 60 adult 
patients undergoing elective partial or total thyroidectomy 
and were placed in three different groups (20 patients in 
each group) 
Group 1 : received Propofol 0.5 mg/kg (15 minutes before 
reversal) 
Group 2 : received Ondensetron 8 mg (15 minutes before 
induction) 
Group 3: received Dexamethasone 10 mg (15 minutes 
after induction).Patients were instructed not to receive 
anything by mouth for at least 8 hours before surgery. 
Patients were premedicated with Tab. Lorazepam night 
before surgery and Tab. Diazepam in the morning on the 
day of surgery. Anaesthetic technique was identical in all 
patients. Induction of anaesthesia was done with Inj. 
Glycopyrrolate 0.01 mg/kg IV, Inj. Fentanyl 1.5-2 mcg/kg 
IV, Inj. Thiopentone Sodium 5 mg/kg and Inj. 
Succinylcholine 1.5 mg/kg.  Anaesthesia was maintained 
with O2 + N2O and volatile inhalational anaesthetics like 
sevoflurane or isoflurane. Intermittent positive pressure 
ventilation was used for ventilation and Inj. Vecuronium 
bromide as a muscle relaxant intraoperatively. Intra 
operatively patients were monitored with pulse oximetry, 
ECG and non invasive blood pressure. After completion 
of surgery reversal of anesthesia was done with Inj. 
Glycopyrrolate 0.02 mg/kg and Inj. Neostigmine 0.05 
mg/kg and after full muscle tone and power, trachea was 
extubated. Postoperatively, all patients were assessed for 
nausea, vomiting, Heart Rate, Blood Pressure, Respiratory 
Rate and SPO2 for every 4 hrs post operatively for 24 hrs 
except during sleep. PONV was evaluated on 4 point 
ordinal scale (0-No Symptom, 1-Nausea, 2-Retching,3-
Vomiting).The primary clinical endpoint was “complete 
response”, defined as no vomiting and no anti emetic 
drugs needed in the first 24 hrs post operative period. 
Nausea was defined as a subjectively unpleasant 
sensation associated with awareness of the urge to vomit. 
Retching refers to spasmodic respiratory movements 
conducted with a closed glottis. Vomiting was the 
forceful expulsion of gastric contents from the mouth. 
Rescue antiemetic Inj. Ondensetron 8 mg i.v was given on 
patient demand or nausea, vomiting or retching was 
recorded. If both nausea and vomiting were present in a 
particular period it was recorded as vomiting only by the 
virtue of being higher on the ordinal scale. Postoperative 
pain at the surgical site was assessed by using VAS scale 
(0-No Pain to 10-Most Severe Pain) and recorded every 4 
hr post operatively for 24 hr except during sleep. All the 
patients were given Inj. Diclofenac Sodium 1.5 mg/kg i.m 
(max. 75 mg) as analgesic at 8 hr intervals after surgery or 
earlier if they demanded pain relief. Occurrence of sore 
throat was recorded and treated with 7% povidone-iodine 
gargle solution. Sedation score was assessed by using 
following scale (0 - Completely Awake, 1 – Awake but 
drowsy, 2 - Asleep but responds to verbal commands, 3 - 
Asleep but responds to physical stimulation, 4 - 
Unarousable).  Chi-Square test with Yates correction and 
Student’s T test were used as the tests of significance to 
evaluate efficacy of anti emetics to prevent PONV and 
other quantitative data obtained in the postoperative 
period. P<0.05 was considered statistically significant. 
Results  
 60 adult patients undergoing thyroidectomy procedure 
that were selected for the study and divided amongst the 
three groups (20 patients in each group) had the following 
parameters. 
Table 1: Demographic Data 
 Group-1 Group-2 Group-3 
Age (yrs) 43.65(19-68) 46.8(20-70) 42.75(25-64) 
Sex(F/M)(n) 16/4 15/5 15/5 
Weight (kg) 50.4+9.96 53.4+7.31 51.1+6.59 
Height(cms) 160+6.8 159.4+7.4 149.6+6.8 
History of previous surgery 3 1 2 
Duration of anaesthesia(hrs) 2.06+0.46 2.0+0.57 1.98+0.42 
Values are given as mean (+SD) or mean (range) or number of patients. 
There was no significant difference in the parameters mentioned above in between the three groups. 
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Table 2:No. of pts (%) with Nausea, Vomiting and Retching requiring rescue anti emetic at 4 hrs interval post 
operatively 
 Group – 1 Group – 2 Group - 3 
0 – 4 hr    
Total(Nausea, Vomiting, Retching) 1(5%) 1(5%) 2(10%) 
Rescue antiemetic 1(5%) 1(5%) 2(10%) 
4-8 hrs    
Total(Nausea, Vomiting, Retching) 1(5%) 1(5%) 1(5%) 
Rescue antiemetic 1(5%) 1(5%) 1(5%) 
8-12 hrs    
Total(Nausea, Vomiting, Retching) 2(10%) 2(10%) 1(5%) 
Rescue antiemetic 2(10%) 2(10%) 1(5%) 
12-16 hrs    
Total(Nausea, Vomiting, Retching) 2(10%) 0(0%) 0(0%) 
Rescue antiemetic 2(10%) 0(0%) 0(0%) 
16-20 hrs    
Total(Nausea, Vomiting, Retching) 1(5%) 1(5%) 0(0%) 
Rescue antiemetic 1(5%) 1(5%) 0(0%) 
20-24 hrs    
Total(Nausea, Vomiting, Retching) 0(0%) 0(0%) 0(0%) 
Rescue antiemetic 0(0%) 0(0%). 0(0%) 
 
In first 4 hrs interval occurrence of PONV is 5% - group 1, 5% - group 2,, and 10% - group 3. 
In 4-8 hrs interval the incidence of PONV is 5% -group 1, 5%- group 2, 5%- group 3. 
In 8-12 hrs interval the incidence of PONV is comparable between group 1, 2 and 3 (10%, 10% and 5% 
respectively). 
In 12-16 hrs interval the incidence of PONV is comparable between group 2 and 3 (0% and 0%), while it is 
significantly high in group 1 (10%). 
In 16-20 hrs interval the incidence of PONV is 5% in group 1 and 2, while there is complete response (no PONV) in 
group 3.Complete response (no PONV) in the 20-24 hrs interval occurred in 100% of patients in all the three groups. 
There was no significant difference between the requirements of rescue anti emetic between the three groups at any 
period of interval. 
                                 
Table 3: Nausea, Vomiting and Retching in our Patients 
 
Grading Group 1 Group 2 Group 3 
Nausea 3 1 2 
Vomiting 4 4 1 
Retching 0 0 1 
P value 0.3574 0.2481 0.4257 
P value result shows that there were no significant occurrence of Post Operative Nausea and Vomiting. 
 
Table 4: Mean pulse rate and mean arterial pressure at various time intervals after the completion of surgery 
Time Group – 1 Group - 2 Group – 3 
0-4 hr    
Pulse rate 77.7+6.53 77+7.21 76.6+6.12 
MAP 90.95+7.02 90.15+7.77 87.65+7.80 
4-8 hrs    
Pulse rate 80.2+6.48 79.8+5.9 77.3+5.81 
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MAP 94.55+6.37 92.4+6.69 88.7+7.80 
8-12 hrs    
Pulse rate 79.7+9.45 81.5+8.6 76.4+7.52 
MAP 95.25+7.01 94.45+5.67 88.6+8.22 
12-16 hrs    
Pulse rate 80.9+10.31 82.7+6.5 77.6+8.64 
MAP 96.15+6.04 93.2+5.37 91.35+7.07 
16-20 hrs    
Pulse rate 82.1+7.8 83.8+5.57 79+7.24 
MAP 97.4+5.93 93.65+6.72 91.5+7.03 
20-24 hrs    
Pulse rate 80.5+6.41 83.7+6.49 79.6+7.44 
MAP 96.65+5.34 93+7.8 91.3+6.86 
The difference in blood pressure (MAP) and pulse rate was not statistically significant between the three groups at 
any measured time interval after surgery. 
 
Table 5:No. of pt (%) with Sore Throat Using VAS Score 
Time Group-1 Group-2 Group-3 
0-4 hrs 0(0%) 1(5%) 0(0%) 
4-8 hrs 2(10%) 1(5%) 1(5%) 
8-12 hrs 0(0%) 1(5%) 2(10%) 
12-16 hrs 1(5%) 0(0%) 0(0%) 
16-20 hrs 3(15%) 0(0%) 0(0%) 
20-24 hrs 0(0%) 2(10%) 0(0%) 
Sore Throat was reported by some patients with different intensity amongst groups. Patients in Group-3 reported a 
lower pain score of sore throat than those in the other two groups. 
 
Table 6: Pain scores at various time intervals (when Patient in awake state) after surgery (Mean + SD) 
 
Pain Score Group – 1 Group – 2 Group – 3 
0-24 hrs 3.5+2.21 3.45+2.30 3.25+2.76 
Inj Diclofenac 
Sodium(mg) 
72+1.2 73.6+2.07 70.8+0.6 
Pain Score (VAS Score) was observed amongst three group which was found not to be different significantly 
statistically. The analgesic consumption was not statistically different significantly between the three groups. 
 
Table 7: Sedation score in all patients (Mean Value) 
 
Sedation Score Group 1 Group 2 Group 3 
0-24 hrs 1.8 1.2 0.9 
None of the pts had sedation scores more than 2 (Asleep but respond to verbal command) during post operative 
period of 24 hrs. 
Table 8: Side effects at 24 hrs 
 
 Group – 1 Group – 2 Group – 3 
Headache 0 2 0 
Sweating 0 0 0 
Dizziness 1 0 0 
Itching 1 1 0 
Rashes 0 0 1 
No significant difference was noted in occurrence of side effects amongst three groups. 
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Discussion 
Postoperative nausea and vomiting (PONV) is one of 
the most common and annoying problem after general 
anaesthesia and is intractable at time. It may be 
relatively benign at times and sometimes it can lead to 
severe sequelae such as aspiration of stomach contents 
and poor surgical outcome especially after abdominal 
surgeries.Patients undergoing thyroid surgery are at 
high risk for development of PONV. The incidence of 
PONV after thyroidectomy in adult women is relatively 
high about 76% when no anti emetic was given and the 
etiology is unknown.[1] Several factors including the 
age, gender,  obesity, previous history of motion 
sickness or PONV, anxiety, gastroparesis, type and 
duration of the surgical procedure (e.g., laparoscopy, 
strabismus, middle ear procedures) , and intense vagal 
stimulation might be related to PONV. 
Anesthesiologists have little, if any, control over these 
surgical factors. However, they do have control over 
many other factors that influence post operative emesis 
(e.g., pre anesthetic medication, anesthetic drugs and 
techniques, and postoperative pain management.[2-4] 
Most of the currently used antiemetic drugs (e.g. 
anticholinergics, dopamine receptor antagonist, and 
antihistamines) have clinically significant side effects. 
(e.g., dysphagia, restlessness, dry mouth, changes in 
blood pressure and extra pyramidal symptoms.[1] In 
this clinical study, the treatment groups were similar 
with regard to demographics & operative procedure. 
Patients with history of motion sickness or previous 
history of emesis were excluded because they had a 
relatively high incidence of emetic symptoms.[5]  
Dexamethasone may involve central inhibition of 
prostaglandin synthesis and/or decrease in serotonin 
turn over in CNS. Strong anti inflammatory effect of 
dexamethasone on neck structures may also play a role 
in its anti emetic effect in patients undergoing 
thyroidectomy. In these patients, significant oedema 
and inflammation around the neck may sustain evoked 
parasympathetic impulses through vagus, recurrent 
laryngeal and glossopharyngeal nerves to the vomiting 
centre, thus initiating vomiting responses. 
Dexamethasone may significantly reduce tissue 
inflammation around the neck and thus reduces the 
ascending parasympathetic impulse to the vomiting 
centre and reduce PONV.[4]  Incidence of PONV has 
been significantly decreased by single dose steroid 
administration in several studies.[6-8]  Dexamethasone 
has been shown to have anti emetic effect and the dose 
commonly used is from 5 – 10 mg. Recently, 
dexamethasone has been proved to be effective in 
prevention of PONV in females undergoing 
thyroidectomy and the minimum effective dose is 5 
mg.[2] However, patients who received dexamethasone 
8 – 10 mg enjoyed a higher chance of complete 
response and reduction in analgesic requirement than 
those who received dexamethasone 5 mg.[4,9,10] So 
we used 10 mg dexamethasone immediately after 
induction of anesthesia.The long term administration of 
corticosteroids causes side effects such as increase risk 
of infection, glucose intolerance, delayed wound 
healing, superficial ulceration of gastric mucosa, and 
adrenal suppression.[11] However, these side effects 
were not related to a single dose of dexamethasone[11-
13] We did not have any post operative complication in 
the form of wound infection or delayed wound healing 
[14].Dexamethasone was not found to be effective 
during 0 to 2 hrs after administration because of 
delayed onset of action. It proved to be effective in the 
later period. So we used to give it within short period 
of induction of anesthesia.[12] Dexamethasone has a 
biological half life of 36 to 72 hours. Thus, the late 
antiemetic efficacy may be a result of favourable 
pharmacokinetics. In chemotherapy, there is some 
evidence that delayed emesis (i.e., beyond 24 hours) is 
better controlled with dexamethasone compared with 
classic antiemetics.[15] Propofol is relatively selective 
modulator of GABAA receptors.  Interaction of 
propofol with specific components of GABA receptors 
appear to decrease the rate of dissociation of GABA 
from the receptor thereby increasing the duration of 
GABA activated opening of chloride channel causing 
hyperpolarisation of cells.[16] Low dose of propofol 
may induce anxiolysis sufficient to modify cortical 
afferent to the vomiting centre.[17] It has been 
postulated that antiemetic effect of propofol may be as 
an antagonist at the 5-HT3 receptor. The antiemetic 
effect of propofol may be due to modulation of sub 
cortical pathways.[18] Propofol, in small doses, 
possesses direct antiemetic properties. Single small 
dose (0.5 mg/kg) of propofol administered 
intravenously at the end of surgery before reversal was 
more effective than traditional anti emetics for 
prevention of PONV.[19] Subhypnotic dose of 
propofol was not only superior in comparison with 
placebo to control the incidence of emesis, but also 
without unwanted sedative, respiratory or 
cardiovascular side effects.[18] In our study we did not 
find any serious side effects amongst patients.Propofol 
is a cost effective alternative to newer antiemetic drugs 
for the treatment of refractory postoperative nausea and 
vomiting.[20]  Ondansetron, a selective 5 HT3 
antagonist has been shown to be effective in preventing 
nausea and vomiting during the perioperative 
period.[21] Anti emetic effort results from peripheral 
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blockade of 5 HT3 receptors, on vagal nerve terminals 
and central blockade in the area of postrema and 
nucleus solitaries. This equates with chemoreceptor 
trigger zone (CTZ) blockade. 5 HT3 receptor 
antagonists have no affinity for alpha adrenergic, 
dopaminergic or histamine receptors. This 
characteristic eliminates undesirable side effects of 
sedation, hypotension and extra pyramidal reactions 
that occur when using other non selective anti emetic 
agents.[22]The effectiveness of intravenous 
ondansetron as a prophylactic post operative antiemetic 
was evaluated in a dose ranging study and it was 
demonstrated that a single 4 mg dose appeared to be 
the lowest acceptable dose to prevent PONV.[23-25] 
However, The optimal intravenous dose of ondansetron 
to prevent PONV is likely to be 8 mg for long term 
efficacy.[26] Ondansetron is a highly effective 
antiemetic that has been used successfully for both the 
prophylaxis and treatment of postoperative nausea and 
vomiting. For the efficacy of ondansetron as a 
prophylactic antiemetic, investigators have 
administered the drug immediately before induction of 
anesthesia. Duration of ondansetron’s antiemetic 
efficacy is dose related. Although the timing of 
administration of ondansetron did not influence the 
overall incidence of PONV, the need for rescue 
antiemetic medication in the PACU was significantly 
decreased in the patients who received ondansetron at 
the end of surgery.[21] Ondansetron has a relatively 
short half life of 2.8+0.6 hrs after a single 8 mg 
intravenous dose.[27] As we used to give ondansetron 
immediately before induction of anesthesia, we 
reported some more no. of cases of PONV in first 6-8 
hrs postoperatively. In the post operative period both 
pain and opioids have been reported to increase the 
incidence of PONV. In the logistic regression models 
of the risk factors for PONV, the use of post operative 
opioid was included while the use of intra operative 
opioid was not. According to the data of today, there is 
no clear cut association between use of intra operative 
opioid and PONV.[28,29] So we used intra operative 
Fentanyl for all our patients undergoing thyroidectomy 
surgery In our study we found that Propofol in 
subhypnotic dose was effective to prevent PONV and 
is associated with fewer requests for rescue antiemetic 
and sedation in the early phase of recovery. It is 
equally effective in preventing postoperative nausea as 
Ondansetron in the first 6 hrs after operation. A single 
dose of Dexamethasone is safe and is comparable to 
Ondansetron in preventing PONV. We found that 
delayed emesis is better controlled with 
Dexamethasone compared with other groups. All three 
groups found to be effective in preventing PONV as a 
complete response in later part of post operative period. 
There was no significant difference in the demographic 
parameters amongst three groups.  We did not observe 
significant difference in MAP, Pulse rate, Pain Score, 
and Total Analgesic consumption in between three 
groups. No patients had sedation score more than 2. 
Sedation score was found to be least in Ondansetron 
and Dexamethasone groups. We found occurrence of 
sore throat much less in group receiving 
Dexamethasone. Complications were few and were 
evenly distributed without any statistically significant 
difference between the three groups.  
Conclusion 
  Overall incidence of postoperative nausea and 
vomiting in the 24 hour period after giving propofol, 
ondansetron and dexamethasone was 35%, 25% and 
20% respectively. Statistically significant difference 
was noted in the incidence of PONV between Group III 
and Group I and II. Similar efficacy was found in all 
the three groups for prevention of postoperative nausea 
and vomiting in patients undergoing thyroidectomy 
surgery. Ondansetron is effective to prevent 
postoperative nausea and vomiting. A single low dose 
of dexamethasone is safe and is comparable to 
ondansetron to prevent PONV. Prolonged effects of 
dexamethasone may prove to especially beneficial in 
limiting PONV. Propofol given at subhypnotic dose 
significantly decreases the incidence of emetic 
episodes in patients undergoing thyroidectomy surgery 
without clinically important adverse events. However, 
all the three drugs were significantly effective to 
prevent PONV compared with placebo. 
Abbreviations: 
          ASA     -    American Society of Anesthesiologist 
          CTZ      -    Chemoreceptor Trigger Zone 
          ECG      -    Electrocardiogram 
          GABA   -    Gamma Amino butyric Acid 
          Kg        -    Kilogram 
          MAP    -    Mean Arterial Pressure 
           Max     -    Maximum 
           Mcg      -   Microgram 
           Mg        -   Milligram 
           Min       -   Minute 
           PONV    -   Postoperative Nausea and Vomiting 
Acknowledgements 
We thank K. Vadhia for their assistance in this project 
and help in stastical analysis. 
References 
1. Watcha MF, White PF. Postoperative nausea 
and vomiting: its etiology, treatment and 
prevention. Anesthesiology 1992;77: 162–84  
 
Asian Pac. J. Health Sci., 2015; 2(4):65-72                                              e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Patel et al     ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2015; 2(4):65-72 
www.apjhs.com      71 
 
2. Yi Lee, Pei chin lin, Hsien yong lai. 
Prevention of Postoperative nausea and 
vomiting with dexamethasone in female 
patients undergoing desflurane anesthesia for 
thyroidectomy. Acta Anesthesiology 2001; 
39:151-6. 
3. Sonner JM, Hynson JM, Clark O. Katz JA. 
Nausea and vomiting following thyroid and 
parathyroid surgery. J Clin Anesthe. 
1997;9(5):398-402 
4. Jhi Joung Wang, Shung Tai, Shih Chun Lee, 
Yun Hou Liu, Yuan Chung Liao. The 
prophylactic effect of dexamethasone on 
postoperative nausea and vomiting in women 
undergoing thyroidectomy: A comparison of 
droperidol with saline. Anesthesia and 
Analgesia 1999; 89:200-203 
5. P.Ewalenko,S.Jenny,M.Dejonckheere, G. 
Andry, C.Wyns. Antiemetic effect of 
subhypnotic dose of propofol after 
thyroidectomy. British J Anesthesia 
1996;77:463-467 
6.  P.Gupta,J Khanna,A K Mitramustafi, V K 
Bhartia. Role of pre operative dexamethasone 
as prophylaxis for postoperative nausea and 
vomiting in laparoscopic surgery. Journal of 
Minimal Access Surgery March 2006;2(1):17 
7. Callery MP. Preperative steroids for 
laparoscopic surgery. Ann Surg 
2003;238:661-2. 
8. Wang JJ, Ho ST, Liu HS , Ho CM. 
Prophylactic antiemetic effects of 
dexamethasone in woman undergoing 
ambulatory laparoscopic surgery. British J 
Anesthesia 2000;84:459-62. 
9. Fujii Y, Nakayama M. Dexamethasone for 
reduction of nausea, vomiting and analgesic use 
after gynecological laparoscopic surgery. Int J 
Gynecol Obstet 2008;100(1):27-30 
10. K. Liu, C.C.Hsu, Y.Y. Chia. Effect of 
Dexamethasone   on post operative emesis and 
pain. British J Anaesthesia 1998, 80:85-86 
11. Jhi Joung Wang, Shung Tai Ho, Shih Chun 
Lee, Yao Chi Liu and Chiu Ming Ho. The use 
of Dexamethasone for preventing 
postoperative nausea and vomiting in females 
undergoing thyroidectomy: A dose ranging 
study. Anesthesia and Analgesia 
2000;91:1404-7 
12. Iris Henzi, Bernhard Walder, and Martin R. 
Tramer. Dexamethasone for the prevention of 
postoperative nausea and vomiting : A 
quantitative systematic review. Anesthesia 
and Analgesia 2000 ;90 :186-94. 
13. Tong J. Gan, Tricia Meyer, Christian C. 
Apfel, Frances Chung, Peter J. Davis, Steve 
Eubanks, Anthony Kovac, Beverly K. Philip, 
Daniel I. Sessler, James Temo, Martin R. 
Tramer and Mehernoor Watcha. Consensus 
guidelines for managing postoperative nausea 
and vomiting. Anesthesia and analgesia 
2003;97: 62-71 
14. Kang Liu, Chi Chang Hsu, and Yuan Yi Chia. 
The effective dose of Dexamethasone for anti 
emesis after major gynaecological surgery. 
Anesthesia and Analgesia 1999; 89:1316-8. 
15. Jhi Joung Wang, Shung Tai Ho, Jann Inn 
Tzeng, and Chao Shun Tang. The effect of 
timing of Dexamethasone administration on 
its efficacy as a prophylactic antiemetic for 
postoperative nausea and vomiting. 
Anesthesia and Analgesia 2000;91:136-9. 
16. Robert K. Stoelting, Simon C. Hillier. 
Pharmacology and Physiology in Anesthetic 
practice. Fourth edition 2006;155-63. 
17. Ewalenko P, Janny S, Dejonckheere M, Andry 
G and Wyns C. Antiemetic effect of 
subhypnotic doses of propofol after 
thyroidectomy. British Journal of Anesthesia , 
1996;77;463-7. 
18. A Rudra, R Halder, A Sen, S Kundu. Efficacy 
of low dose propofol for control of emetic 
episodes during caesarean delivery with spinal 
aneshtesia. Indian Journal Anesthesia 
2004;48(1):31-34. 
19. Mitsuko Numazaki, Yoshitaka Fujii. 
Antiemetic efficacy of propofol at small doses 
for reducing nausea and vomiting following 
thyroidectomy. Canadian Journal of 
Anesthesia 2005;52: 333-334. 
20. Scott R. Schulman, Carol B. Rockett, Andrew 
T. Canada, and Peter S. A. Glass. Long Term 
Propofol infusion for refractory postoperative 
nausea: A case report with quantitative 
propofol analysis. Anesthesia and Analgesia: 
1995;80:636-637. 
21. Rui sun, Kevin W. Klein, and Paul F. White. 
The effect of timing of ondansetron 
administration in outpatients undergoing 
otolaryngologic surgery. Anesthesia and 
Analgesia ; 1997;84: 331-336 
22. Robert K. Stoelting, Simon C. Hilier. 
Pharmacology and Physiology in Anesthetic 
practice. Forth edition 2006: 446-449. 
23. Pearman MH.Single dose intravenous 
ondansetron in the prevention of postoperative 
nausea and vomiting. Anesthesia 1994;49:11-
5. 
 
Asian Pac. J. Health Sci., 2015; 2(4):65-72                                              e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Patel et al     ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2015; 2(4):65-72 
www.apjhs.com      72 
 
24. Joslyn AF. Ondansetron, clinical development 
for postoperative nausea and vomiting: current 
studies and future directions. Anesthesia 1994: 
49 : 34-37. 
25. L. Lopez Olaondo, F. Carrascosa, F.J.Pueyo, 
PlMonedero, N. Busto and A. Saez. 
Combination of Ondansetron and 
Dexamethasone in the prophylaxis of 
postoperative nausea and vomiting. British 
Journal of Anesthesia 1996;76: 835-840 
26. Martin R. Tramer, John M. Reynold, R. 
Andrew Moore. Efficacy, Dose-Response and 
Safety of Ondansetron in prevention of 
postoperative nausea and vomiting. 
Anesthesiology 1997; 87(6):1277-1289 
27. T.J. Gan, B. Ginsberg, A. Pl Grant, 
P.S.A.Glass. Double blind, Randomized 
comparison of ondansetron and intraoperative 
propofol to prevent postoperative nausea and 
vomiting. Anesthesiology 1996;85(5):1036-42 
28. Apfel CC, Greim CA, Haubitz I et al. A risk 
score to predict the probability of post 
operative nausea and vomiting in adults. Acta 
Anesthesiology. Scand 1998; 42:495-501. 
29. Koivuranta M. Laara E, Snare L et al.  A 
survey of post operative nausea and vomiting. 
Anesthesia 1997; 52: 443-449. 
           
 
Source of Support: Nil                                     
Conflict of Interest: None  
 
